TSHA
Taysha Gene Therapies Inc
$6.70
0.11 (1.69%) Today
— up— down
Market Cap
$1.96B+185.9%
Revenue (TTM)
$5.86M+3.4%
Net Income (TTM)
$-108,162,304
$-108,162,304EPS (TTM)
-0.38
-0.38Shares Out
287.36M
287.36MOpen
$6.76
$6.76Previous Close
$6.81
$6.81Day Range
$6.64 – $6.85
$6.64 – $6.8552-Week Range
$2.33 – $7.30
$2.33 – $7.30Beta
1.25
1.25Volume
779.76K
779.76KAvg Volume
2.92M
2.92MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout TSHA
Related
News
Taysha: 'Buy' On Interim Analysis Of TSHA-102 First Half 2027 And Broad Label Potential
SeekingAlpha · 1d ago
Baird Maintains Outperform on Taysha Gene Therapies, Raises Price Target to $15
Benzinga · 1d ago
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
Yahoo · 5d ago
Taysha Gene Therapies Announces Multiple Presentations Highlighting TSHA-102 Program In Clinical Evaluation For Rett Syndrome At 2026 IRSF Rett Syndrome Scientific Meeting
Benzinga · 5d ago
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Yahoo · 6d ago